Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:25 PM UTC
| NCT Number | NCT06361537 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Angioedema |
| Phase | PHASE3 |
| Target Enrollment | 124 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | June 30, 2026 (2 weeks ago) |
As of July 20, 2026: Clinical trial NCT06361537 is currently recruiting participants. This phase3 study for hereditary angioedema is actively seeking new participants at 3 locations across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06361537 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06361537 was last updated 2 weeks ago (June 30, 2026). HelloStudys verifies this status automatically.